Dr. Saleem A. Waraich, MD

Dr. Waraich practices at UCI Health - Placentia Linda in Placentia, California, part of UC Irvine.

Dr. Waraich's NPI, 1164601332, was assigned on October 24, 2007. Dr. Waraich graduated from New York University School of Medicine in 2004. Dr. Waraich's California license number on file is A93667.

Dr. Waraich's primary practice is UCI Health - Placentia Linda, at 1301 N Rose Drive, Placentia, CA 92870.

Dr. Waraich's primary practice is UCI Health - Placentia Linda in Placentia, California, part of UC Irvine. Dr. Waraich is also affiliated with UCI Health - Orange. The medical group on file is Chest and Critical Care Consultants. Dmand AI also links Dr. Waraich to 1 more physician office, 1 group practice or clinic, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Waraich practices, 5 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Waraich's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Waraich is board certified in rheumatology by the American Board of Internal Medicine. Dr. Waraich has a license on file in California.

Dmand AI lists arteritis, arthritis, gout, joint pain, lupus, muscle pain, fibromyalgia, and limb pain, osteoporosis and purpura and thrombocytopenia among the conditions Dr. Waraich treats.

CMS data shows 1,256 Medicare services from Dr. Waraich across 9 procedure codes in 2024, for 320 Medicare patients. Medicare paid $86,939 for them. Every service was in an office.

CMS counts 320 Medicare patients who saw Dr. Waraich in 2024. The largest group is 65 to 74, with 151 patients. 75% of them have arthritis, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Waraich's median patient age at 67, with 75% women.

In 2024, Dr. Waraich wrote 4,189 Medicare Part D claims for 460 patients. 86% of them were for generic drugs. CMS names the drug for 3,927 of them, across 49 drugs with 11 or more claims each, at $1,833,702 in total drug cost. In 2023, CMS named 4,094 claims across 49 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Waraich for performance year 2024, reported as part of a group. Dr. Waraich accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Waraich as offering telehealth.

Dmand AI links 1 paper to Dr. Waraich.

CMS Open Payments shows 250 general payments to Dr. Waraich from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Amgen Inc. paid the most, $1,167.

Dr. Waraich graduated from New York University School of Medicine in 2004.

Dr. Waraich is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.